Jan 09 2025 21 mins 1
Visit https://www.peervoice.com/RUF860 to view the entire programme with slides. After completing “Yves Robitaille, MD, CSPQ, DABOM - Cardiovascular Risk Management in Patients Living With Obesity: Applying the Latest Evidence to Practice”, participants will be able to: Describe the association between obesity and the risk of cardiovascular disease (CVD); Evaluate the latest clinical evidence of various therapeutic options, including GLP-1 receptor agonists, in patients living with obesity and CVD; Discuss comprehensive treatment strategies to improve cardiovascular risk in patients living with obesity, incorporating both pharmacologic and non-pharmacologic approaches; and Formulate individualized approaches to manage side effects associated with different therapeutic options and improve their uptake in suitable patients.
